Home » whitepapers » Putative prostate cancer (PCa) biomarker NAG detection is possible with H6D polymorphism monoclonal and polyclonal antibodies from Rockland Immunochemicals

Rockland Immunochemicals, Inc.

White Paper

Putative prostate cancer (PCa) biomarker NAG detection is possible with H6D polymorphism monoclonal and polyclonal antibodies from Rockland Immunochemicals

Download to find out more.

Download White Paper